Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Revolution Medicines, Inc. (RVMD) had Return on Equity of -30.26% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-453.82M |
|
-- |
|
-- |
|
$445.22M |
|
$-445.22M |
|
$-8.59M |
|
$-453.82M |
|
$-453.82M |
|
$-453.82M |
|
$-453.82M |
|
$-453.82M |
|
$-453.82M |
|
$-445.22M |
|
$-443.91M |
|
198.10M |
|
198.10M |
|
$-2.29 |
|
$-2.29 |
|
| Balance Sheet Financials | |
$1.97B |
|
$31.48M |
|
$285.82M |
|
$2.25B |
|
$289.60M |
|
$280.64M |
|
$464.22M |
|
$753.82M |
|
$1.50B |
|
$1.43B |
|
$1.50B |
|
200.18M |
|
| Cash Flow Statement Financials | |
$-354.17M |
|
$172.62M |
|
$238.74M |
|
$388.60M |
|
$445.80M |
|
$57.19M |
|
$87.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.80 |
|
-- |
|
-- |
|
0.16 |
|
0.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-355.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-30.26% |
-31.75% |
|
-20.14% |
|
-25.49% |
|
$7.49 |
|
$-1.80 |
|
$-1.79 |
|